Date published: 2025-10-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

A430033K04Rik Activators

A430033K04Rik Activators encompass a range of chemical compounds that engage with various cellular signaling pathways to amplify the functional activity of A430033K04Rik. Forskolin, by augmenting intracellular cAMP levels, can boost A430033K04Rik activity through PKA-dependent mechanisms, assuming A430033K04Rik's involvement in such cAMP-responsive pathways. Similarly, Genistein and Epigallocatechin gallate (EGCG) could enhance A430033K04Rik's function by attenuating competitive kinase signaling, potentially shifting the balance towards A430033K04Rik-associated pathways. Glucokinase activators are compounds that either directly enhance the enzyme's substrate processing or indirectly influence its activity through modulation of related metabolic pathways. Glucose, as the primary substrate, directly promotes Glucokinase activity, with increased glucose levels resulting in a higher rate of glucose-6-phosphate production. Additionally, ATP serves as a phosphate donor in the Glucokinase reaction, while Magnesium ions are crucial for ATP's structural stability when interacting with Glucokinase, both contributing to heightened enzyme activity. A430033K04Rik Activators denote a class of chemicals that can stimulate the expression of the A430033K04Rik gene.

To identify compounds that can act as activators, researchers utilize a high-throughput screening (HTS) strategy. This technique leverages a reporter gene assay, a system in which a reporter gene-typically encoding a readily measurable product like a fluorescent or luminescent protein-is placed under the control of the A430033K04Rik gene promoter. When a diverse array of chemical substances is introduced to a cellular system containing this reporter construct, activator compounds can be identified by an increase in the reporter's signal, indicating promoter activation. This increase in signal directly correlates to the compound's ability to enhance the activity of the A430033K04Rik promoter. Compounds that result in a significant elevation in signal are then selected for more detailed examination to verify their role as activators of the A430033K04Rik gene.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

EGCG inhibits several protein kinases, altering signaling pathways such as the MAPK pathway, which could lead to the activation of A430033K04Rik if it is implicated in these pathways.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$162.00
$316.00
$559.00
$889.00
$1693.00
7
(1)

S1P binds to its G-protein-coupled receptors, influencing downstream signaling pathways that can enhance A430033K04Rik function if it is coupled to these lipid signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor that by reducing PI3K/Akt signaling can indirectly activate A430033K04Rik by shifting the balance towards pathways that A430033K04Rik is involved in.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 inhibits MEK, which may lead to the activation of A430033K04Rik by modulating the MAPK/ERK pathway if A430033K04Rik is associated with this pathway.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 is a p38 MAPK inhibitor, which can enhance A430033K04Rik function by altering the p38 MAPK signaling pathway that A430033K04Rik may participate in.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Thapsigargin disrupts calcium homeostasis, potentially enhancing A430033K04Rik activity through the activation of calcium-dependent signaling if linked to A430033K04Rik's function.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Although a broad-spectrum kinase inhibitor, Staurosporine could selectively enhance A430033K04Rik signaling pathways by inhibiting kinases that negatively regulate pathways associated with A430033K04Rik.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA activates PKC, which may lead to the enhancement of A430033K04Rik by modulating signaling pathways that involve diacylglycerol and protein kinase C, if A430033K04Rik is part of these pathways.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially enhancing A430033K04Rik activity by activating calcium-dependent proteins and pathways associated with A430033K04Rik's function.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin is another PI3K inhibitor that could indirectly activate A430033K04Rik by shifting cell signaling dynamics away from PI3K/Akt pathway to pathways in which A430033K04Rik is involved.